Treace Medical Concepts, Inc. is a healthcare company based in the United States, with an ESG risk rating score of 27.8, signifying medium risk. Specializing in orthopaedic medical devices, Treace is leading the way in bunion deformity management with its innovative Lapiplasty 3D Bunion Correction procedure. This patented technique offers a comprehensive solution that addresses the root cause of bunions, allowing patients to quickly return to their active lifestyles. Treace's focus on sustainability, governance, and environmental responsibility sets it apart in the healthcare industry, making it a top choice for physicians, surgeons, and healthcare facilities.